Local treatments like radiotherapy are essential for stage IIIB EGFR mutation-NSCLC patients, but combining EGFR-TKIs with radiation may worsen lung injury due to limited available data [19,20,21]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.